Actemra Approved for Certain Blood Vessel Inflammation

MONDAY, May 22, 2017 -- The injected drug Actemra (tocilizumab) has been approved by the U.S. Food and Drug Administration to treat adults with giant cell arteritis, an inflammation of the blood vessels (vasculitis). In a media release Monday, the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news